NCT05161598 2025-12-16
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
Janssen Research & Development, LLC
No longer available
Clinical Trials
3 trialsNCT05503550 2025-12-16
Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
No longer available
NCT04452994 2025-06-13
Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
Janssen Research & Development, LLC
No longer available